Moffat J F, Stein M D, Kaneshima H, Arvin A M
Department of Pediatrics, Stanford University Medical School, California 94305, USA.
J Virol. 1995 Sep;69(9):5236-42. doi: 10.1128/JVI.69.9.5236-5242.1995.
To investigate the cell tropism and pathogenicity of varicella-zoster virus (VZV) strains, we analyzed VZV replication by using SCID-hu mice that carry human fetal thymus/liver implants under the kidney capsule or as subcutaneous fetal skin implants. MRC-5 cells infected with wild-type VZV or the Oka strain, used in the live attenuated varicella vaccine, were injected into the implants. The implants were surgically removed 2, 7, 14, and 21 days postinfection. The VZV titer from infected thymus/liver implants peaked on day 7 for the wild-type strain and on day 14 for the Oka strain. Histological analysis showed necrotic areas characterized by thymocyte depletion and fibrosis. VZV protein synthesis was detectable by immunohistochemical staining in the necrotic areas and in distant regions that did not show cytopathic changes, and VZV DNA was detected by in situ hybridization in the same distribution. Fluorescence-activated cell sorting analysis of thymocytes harvested at day 7 postinfection showed that VZV proteins were expressed in CD4+, CD8+, and CD4+ CD8+ T cells; VZV was cultured from each T-cell subpopulation. The Oka strain had tropism for human cell types similar to that of wild-type VZV. T lymphocytes released infectious VZV, which is a novel and important observation about the replication of this otherwise highly cell associated virus. VZV-infected skin implants exhibited microscopic epidermal lesions that were indistinguishable histologically from the characteristic lesions of varicella. These experiments demonstrate a unique tropism of VZV for human T lymphocytes, explaining its capacity to cause viremia in natural disease, and demonstrate the value of the SCID-hu model for studies of VZV pathogenesis.
为了研究水痘带状疱疹病毒(VZV)毒株的细胞嗜性和致病性,我们通过使用在肾被膜下植入人胎儿胸腺/肝脏或皮下植入胎儿皮肤的SCID-hu小鼠来分析VZV复制情况。将感染野生型VZV或减毒活水痘疫苗中使用的Oka株的MRC-5细胞注射到植入物中。在感染后2、7、14和21天通过手术取出植入物。感染的胸腺/肝脏植入物中的VZV滴度,野生型毒株在第7天达到峰值,Oka株在第14天达到峰值。组织学分析显示坏死区域的特征为胸腺细胞耗竭和纤维化。通过免疫组织化学染色在坏死区域和未显示细胞病变变化的远处区域可检测到VZV蛋白合成,并且通过原位杂交在相同分布中检测到VZV DNA。对感染后第7天收获的胸腺细胞进行荧光激活细胞分选分析表明,VZV蛋白在CD4 +、CD8 +和CD4 + CD8 + T细胞中表达;从每个T细胞亚群中培养出VZV。Oka株对人类细胞类型的嗜性与野生型VZV相似。T淋巴细胞释放传染性VZV,这是关于这种原本与细胞高度相关的病毒复制的一项新颖且重要的观察结果。VZV感染的皮肤植入物表现出微观表皮病变,在组织学上与水痘的特征性病变无法区分。这些实验证明了VZV对人类T淋巴细胞具有独特的嗜性,解释了其在自然疾病中引起病毒血症的能力,并证明了SCID-hu模型在VZV发病机制研究中的价值。